Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
(NASDAQ:ABSI), VANCOUVER, Wash. and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Guggenheim Securities SMID Cap Biotech Conference in New York, NY. Absci management is scheduled to participate in a fireside chat on Wednesday, […]